U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Non-chlorofluorocarbon aerosol formulations

Patent 5474759 Issued on December 12, 1995. Estimated Expiration Date: Icon_subject December 9, 2013. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

2885427

3261748

3644353

Manufacture of halogenated compounds
Patent #: 4129603
Issued on: 12/12/1978
Inventor: Bell

Aerosol propellant compositions
Patent #: 4174295
Issued on: 11/13/1979
Inventor: Bargigia ,   et al.

Process for the manufacture of 1,1,1,2-tetrafluoroethane
Patent #: 4311863
Issued on: 01/19/1982
Inventor: Gumprecht

Aerosol compositions containing finely divided solid materials
Patent #: 4352789
Issued on: 10/05/1982
Inventor: Thiel

Liquid phase halogen exchange process for the manufacture of 1,1,1,2-tetrafluoroethane
Patent #: 4851595
Issued on: 07/25/1989
Inventor: Gumprecht

Foaming system for rigid urethane and isocyanurate foams
Patent #: 4945119
Issued on: 07/31/1990
Inventor: Smits, et al.

5118494

More ...

Inventors

Assignee

Application

No. 157182 filed on 12/09/1993

US Classes:

424/45, Organic pressurized fluid422/34, Using alkylene oxide422/37, Using halogen or halogen-containing compound424/46, Powder or dust containing514/826ASTHMA

Examiners

Primary: Griffin, Ronald W.

Attorney, Agent or Firm

Foreign Patent References

  • 0372777 EP. 06/13/1990
  • 0379793 EP. 08/13/1990
  • 0384371 EP. 08/13/1990
  • 0403301 EP. 12/13/1990
  • 9007333 WO. 07/13/1990
  • 9104011 WO. 04/13/1991
  • 9111173 WO. 08/13/1991
  • 9111495 WO. 08/13/1991
  • 9111496 WO. 08/13/1991
  • 9114422 WO. 10/13/1991
  • 9200061 WO. 01/13/1992
  • 9200062 WO. 01/13/1992

International Classes

A61K 009/72
C09K 003/30

Abstract

Aerosol formulations substantially free of chlorofluorocarbons for oral and/or nasal administration are described. The formulations comprise 1,1,1,2,3,3,3-heptafluoropropane, a medicament, optionally an excipient and optionally a surfactant. Methods of treatment utilizing the formulations are also described.

Other References

  • Research Disclosure 16265, Oct. 1977
  • Research Disclosure 30161, May 198
PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
PatentsPlus: add to cart
PatentsPlus: add to cartIntelligent turbocharged patent PDFs with marked up images
$16.95more info
 
Sign InRegister
Username  
Password   
forgot password?